TrialMolecular therapy : the journal of the American Society of Gene Therapy2023

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19.

Luigi Aurisicchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.